TP53 and cancer: Another panel of nine AAbs (anti-TP53, C-myc, protein kinase p90, ubiquitin-binding p62, alpha 2-HS glycoprotein AHSG, ubiquitously expressed 14-3-3zeta, Ras-related protein RalA, KH domain-containing protein over-expressed in cancer Koc, and tumor suppressor p16) showed an AUC of 0.91 and identified 79% of ovarian cancer patients presenting with normal CA125 levels [160].